Skip to content
OpenCapital
Get started

Innovate VATE Life Sciences — Total Assets

Other segment segments

Infrastructure
$748.5M+11.4%
Spectrum
$175.7M-1.5%

Other financials

Income statement

See full
Revenue$364.8M+33.0%
Gross profit$53.5M+17.6%
Operating income$10.0M+194%
Net income-$16.8M+31.4%
EPS (diluted)-$1.29+31.7%

Balance sheet

See full
Cash & equivalents$134.6M+297%
Total debt$1.4B+11.6%
Total equity-$256.3M-25.5%
Total assets$936.8M+7.9%

Cash flow

See full
Operating cash flow$45.5M+423%
CapEx$200.0K-95.7%
Free cash flow$45.3M+341%

Valuation

See full
Market cap$254.69M+274%

Where this comes from

Reported directly by Innovate in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Innovate’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innovate's life sciences — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innovate's life sciences — total assets?
Innovate (VATE) reported life sciences — total assets of $8.5M in Q1 2026.
How has Innovate's life sciences — total assets changed year-over-year?
Innovate's life sciences — total assets decreased by 27.4% year-over-year, from $11.7M to $8.5M.
What does life sciences — total assets mean?
The aggregate book value of all resources, including tangible and intangible assets, controlled by the Life Sciences segment. This metric indicates the scale of the segment's operations and the asset base supporting its revenue generation.